搜索临床试验以:抗PD-1抗体camrelizumab
总计6970个结果
-
National Cancer Institute (NCI)主动,不招人Ann Arbor III 期霍奇金淋巴瘤 | Ann Arbor III 期淋巴细胞耗竭型经典霍奇金淋巴瘤 | Ann Arbor III 期混合细胞性经典霍奇金淋巴瘤 | Ann Arbor III 期结节性硬化症经典霍奇金淋巴瘤 | Ann Arbor IV 期霍奇金淋巴瘤 | Ann Arbor IV 期淋巴细胞耗竭型经典霍奇金淋巴瘤 | Ann Arbor IV 期混合细胞性经典霍奇金淋巴瘤 | Ann Arbor IV 期结节性硬化症经典霍奇金淋巴瘤 | 经典霍奇金淋巴瘤 | 富含淋巴细胞的经典霍奇金淋巴瘤美国, 加拿大, 波多黎各
-
Beijing Anzhen Hospital邀请报名
-
Beijing Anzhen HospitalBeijing Friendship Hospital; The First Affiliated Hospital of Dalian Medical University未知
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)终止
-
OHSU Knight Cancer InstituteOregon Health and Science University; Incyte Corporation招聘中
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)主动,不招人复发性神经母细胞瘤 | 局限性可切除神经母细胞瘤 | 局限性不可切除神经母细胞瘤 | 区域性神经母细胞瘤 | 4S期神经母细胞瘤 | 4 期神经母细胞瘤美国, 加拿大, 澳大利亚, 新西兰, 波多黎各
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)暂停造血和淋巴细胞肿瘤 | 既往骨髓增生异常综合征引起的急性髓性白血病 | 慢性粒单核细胞白血病 | 复发性急性髓性白血病 | 难治性急性髓性白血病 | 原始细胞过多的骨髓增生异常综合征 | 复发性急性淋巴细胞白血病 | 难治性急性淋巴细胞白血病 | 复发性混合表型急性白血病 | 难治性混合表型急性白血病 | 缓解期急性髓性白血病 | 缓解期急性淋巴细胞白血病美国
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
Commissariat A L'energie Atomique尚未招聘
-
The University of The West IndiesCaribbean College of Family Physicians撤销
-
First Affiliated Hospital of Harbin Medical UniversityHarbin Medical University完全的
-
Milton S. Hershey Medical CenterUniversity of Pennsylvania完全的
-
TSH Biopharm Corporation Limited完全的
-
Medical Research Council未知
-
Children's Oncology GroupNational Cancer Institute (NCI)主动,不招人I期肾母细胞瘤 | II期肾母细胞瘤 | III 期肾母细胞瘤 | IV 期肾母细胞瘤 | 成人肾母细胞瘤 | Beckwith-Wiedemann综合征 | 儿童肾母细胞瘤 | 弥漫性增生性叶周肾母细胞瘤病 | 肾脏横纹肌样瘤 | V 期肾母细胞瘤美国, 加拿大, 澳大利亚, 新西兰, 波多黎各, 以色列
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)主动,不招人
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID)招聘中
-
Kirby Institute完全的
-
University of Washington尚未招聘Ann Arbor II 期滤泡性淋巴瘤 | Ann Arbor III 期滤泡性淋巴瘤 | Ann Arbor IV 期滤泡性淋巴瘤 | 1 级滤泡性淋巴瘤 | 2 级滤泡性淋巴瘤 | 3a 级滤泡性淋巴瘤 | Ann Arbor II 期边缘区淋巴瘤 | Ann Arbor III 期边缘区淋巴瘤 | Ann Arbor IV 期边缘区淋巴瘤美国
-
National Cancer Institute (NCI)主动,不招人
-
Australasian Leukaemia and Lymphoma GroupMerck Sharp & Dohme LLC未知淋巴瘤,非霍奇金
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Hospital for Special Surgery, New York招聘中
-
Jaime Moore, MD MPHNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Colorado-... 和其他合作者完全的
-
Francisco Andres de la GalaInstituto de Salud Carlos III完全的
-
Unidad Temporal COVID-19 en Centro CitibanamexInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto Nacional de Cardiologia...完全的
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi Company完全的
-
Baylor College of MedicineM.D. Anderson Cancer Center; The Methodist Hospital Research Institute; Center for Cell and Gene...完全的
-
Seoul National University HospitalNational Institute of Food and Drug Safety Evaluation, Korea完全的
-
Hellenic Oncology Research GroupUniversity Hospital of Crete完全的